Neoleukin Therapeutics (Drug Discovery) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $51.6M

Neoleukin Therapeutics (Drug Discovery) General Information

Description

Developer of immunotherapies using de novo protein design technology intended to transform lives. The company used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Pharmaceuticals
Acquirer
Neoleukin Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoleukin Therapeutics (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 08-Aug-2019 $51.6M Completed Generating Revenue
2. Early Stage VC 08-Feb-2019 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Neoleukin Therapeutics (Drug Discovery)’s complete valuation and funding history, request access »

Neoleukin Therapeutics (Drug Discovery) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
UW CoMotion Accelerator/Incubator
WRF Capital Corporate Venture Capital Minority
To view Neoleukin Therapeutics (Drug Discovery)’s complete investors history, request access »

Ready to get started?

Request a free trial

Neoleukin Therapeutics (Drug Discovery) FAQs

  • Where is Neoleukin Therapeutics (Drug Discovery) headquartered?

    Neoleukin Therapeutics (Drug Discovery) is headquartered in Seattle, WA.

  • What industry is Neoleukin Therapeutics (Drug Discovery) in?

    Neoleukin Therapeutics (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Neoleukin Therapeutics (Drug Discovery) a private or public company?

    Neoleukin Therapeutics (Drug Discovery) is a Private company.

  • What is the current valuation of Neoleukin Therapeutics (Drug Discovery)?

    The current valuation of Neoleukin Therapeutics (Drug Discovery) is .

  • What is Neoleukin Therapeutics (Drug Discovery)’s current revenue?

    The current revenue for Neoleukin Therapeutics (Drug Discovery) is .

  • How much funding has Neoleukin Therapeutics (Drug Discovery) raised over time?

    Neoleukin Therapeutics (Drug Discovery) has raised $800K.

  • Who are Neoleukin Therapeutics (Drug Discovery)’s investors?

    UW CoMotion and WRF Capital have invested in Neoleukin Therapeutics (Drug Discovery).

  • When was Neoleukin Therapeutics (Drug Discovery) acquired?

    Neoleukin Therapeutics (Drug Discovery) was acquired on 08-Aug-2019.

  • Who acquired Neoleukin Therapeutics (Drug Discovery)?

    Neoleukin Therapeutics (Drug Discovery) was acquired by Neoleukin Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process